dexmedetomidine has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Meng, FM; Xue, FS; Zhang, JQ; Zhang, W | 1 |
| Chen, Y; Gong, Q; Gong, Z; Jiang, Y; Lv, J; Wang, H; Wei, Y; Xie, Y; Zhang, X; Zhou, L | 1 |
| Wang, M; Wang, N | 1 |
| Hou, X; Kong, M; Ni, H; Shao, Z; Shen, Q | 1 |
| Cheng, D; Li, H; Li, Y; Qu, M; Xing, F; Xing, N; Zhang, W | 1 |
6 other study(ies) available for dexmedetomidine and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K/Akt/HIF-1α signaling pathway.
Topics: Animals; Chromones; Dexmedetomidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypnotics and Sedatives; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Lung Injury; Male; Morpholines; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2016 |
Dexmedetomidine attenuates propofol-induce neuroapoptosis partly via the activation of the PI3k/Akt/GSK3β pathway in the hippocampus of neonatal rats.
Topics: Anesthetics, Intravenous; Animals; Animals, Newborn; Apoptosis; Chromones; Dexmedetomidine; Female; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Morpholines; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Propofol; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; Thiadiazoles | 2017 |
Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K/Akt/mTOR pathway.
Topics: Anesthetics, Inhalation; Animals; Cerebral Cortex; Chromones; Cytokines; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hippocampus; Hypnotics and Sedatives; Inflammation; Morpholines; Neuroprotective Agents; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Random Allocation; Rats, Sprague-Dawley; Sevoflurane; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cell Survival; Cells, Cultured; Chromones; Dexmedetomidine; Disease Models, Animal; Drug Synergism; Gene Knockdown Techniques; Male; Morpholines; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Transfection | 2021 |
The Protective Mechanism of Dexmedetomidine in Regulating Atg14L-Beclin1-Vps34 Complex Against Myocardial Ischemia-Reperfusion Injury.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Autophagy; Autophagy-Related Proteins; Beclin-1; Chromones; Class III Phosphatidylinositol 3-Kinases; Dexmedetomidine; Disease Models, Animal; Morpholines; Myocytes, Cardiac; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2021 |